Watch ONCO. Know when insiders buy.
One email the day a filing lands. Free.
ONCO
Onconetix, Inc.
0.91
+0.00 +0.11%
USD · close Sep 24
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
26
FLAG · shorts 26
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $3.6MP/E —DIV YIELD —FCF YIELD —REV TTM $646K −51.3%NET INCOME −$10.2MNET CASH —52W 0.61 – 206.00SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $17K | −83.9% | 25.1% | −$2.7M | −$2.9M | — | -1.28 | −$1.9M | — | — | Aug 13 |
| Q1 2026 · Mar 31 | $21K | −78.9% | -7.7% | −$10.2M | −$4.2M | — | -6.71 | −$2.1M | — | — | Aug 13 |
| Q4 2025 · Dec 31derived | $304K | −57.4% | 81.6% | −$1.3M | $5.7M | — | 12.58 | −$3.1M | — | — | Mar 13 |
| Q3 2025 · Sep 30 | $304K | −25.4% | 88.6% | −$2.1M | −$8.8M | — | -6.25 | −$3.2M | — | — | Nov 13 |
| Q2 2025 · Jun 30 | $106K | −84.9% | 66.2% | −$1.9M | −$2.4M | — | -237.91 | −$1.4M | — | — | Aug 13 |
| Q1 2025 · Mar 31 | $102K | −85.5% | 45.1% | −$12.6M | −$8.5M | — | -227.25 | −$2M | — | — | May 13 |
| Q4 2024 · Dec 31derived | $712K | — | 92.7% | −$29.1M | −$29.4M | — | 1258.73 | −$918K | $4K | −$922K | Mar 13 |
| Q3 2024 · Sep 30 | $407K | — | 25.9% | −$2.6M | −$3.8M | — | -249.08 | −$1.1M | $2K | −$1.1M | Nov 13 |
| Q2 2024 · Jun 30 | $705K | — | 14.3% | −$13.6M | −$14.3M | — | -2191.59 | −$3.2M | $18K | −$3.2M | Nov 13 |
| Q1 2024 · Mar 31 | $700K | — | 27.0% | −$11.1M | −$11.1M | — | -20.08 | −$5.2M | $5K | −$5.2M | Nov 13 |
| Q4 2023 · Dec 31derived | — | — | — | −$22M | −$22.4M | — | -50.84 | −$4.3M | $0 | −$4.3M | Jun 2 |
| Q3 2023 · Sep 30 | — | — | — | −$4.5M | −$5.3M | — | -12.21 | −$3M | $0 | −$3M | Dec 10 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $815K | 77.6% | −$17.9M | −$14M | -1721.0% | -16.56 | −$9.7M | — | — | — | — |
| FY2024 · to Dec 31 | $2.5M | 41.8% | −$56.5M | −$58.7M | -2325.2% | -1823.39 | −$10.5M | $28K | −$10.5M | — | — |
| FY2023 · to Dec 31 | $58K | -1927.9% | −$36M | −$37.4M | -63986.5% | -87.45 | −$13.6M | $3K | −$13.6M | — | — |
| FY2022 · to Dec 31 | — | — | −$13.5M | −$13.4M | — | -1.10 | −$8.7M | $9K | −$8.7M | $567K | — |
| FY2021 · to Dec 31 | — | — | −$3.4M | −$3.4M | — | -1.26 | −$2M | $2K | −$2M | — | — |
Every number comes from Onconetix, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.